O. H. Frazier

Last updated
O. H. Frazier
O H Frazier MD (cropped).png
Frazier in 2014
Born
Oscar Howard Frazier Jr.

1940
Stephenville, Texas
NationalityAmerican
Education
Occupation Cardiovascular surgeon
Known for
  • First U.S. implantation of the HeartMate II pump into a human
  • First implantation of the Jarvik 2000 into a human
  • First successful implantation of a continuous-flow TAH into a human
Medical career
Profession Cardiovascular surgeon
Institutions Baylor St. Luke's Medical Center
The University of Texas Health Science Center at Houston
Research
Awards ISHLT Lifetime Achievement Award 2018

O. H. "Bud" Frazier is a heart surgeon and director of cardiovascular surgery research at the Texas Heart Institute (THI), best known for his work in mechanical circulatory support (MCS) of failing hearts using left ventricular assist devices (LVAD) and total artificial hearts (TAH).

Contents

His achievements in heart surgery include the implantation of the first long-term LVAD, the pulsatile HeartMate I in 1986, and the replacement of a diseased heart with a continuous flow device using two HeartMate II pumps, in 2011. His most significant achievements have been in the development of the non-pulsatile implantable LVADs, the Jarvik, HeartMate II and HeartWare.

In 1963, Frazier entered medicine at Baylor College of Medicine (BCM) on completion of a degree in history from the University of Texas-Austin. Under the mentorship of at first Michael E. DeBakey at BCM, and then Denton Cooley at the THI, he performed research on the testing of LVADs as a form of MCS. He continued to lead and become significantly influential in heart surgery and the development and clinical implementation of LVADs and his surgical career at the THI has spanned over fifty years.

Other positions have included chief of the transplant service at Baylor St. Luke's Medical Center (part of the Catholic Health Initiatives system) in Houston.

Early life and education

Oscar Howard Frazier Jr. was born and grew up in Stephenville, Texas, in a Methodist household. Both his parents were teachers [1] [2] and his grandfather nicknamed him "Bud" after a distant cousin who was killed in a West Texas saloon shootout at the turn of the nineteenth century. [1]

A "former high school football star", [3] he was initially destined for a career in football, [2] having been asked by Darrell Royal to play for the University of Texas at Austin as a kicker. [1] However, after attending only a few two-a-day football practices, a leg injury ended his football career. [2] Despite this, he later became a black belt in Karate. [2]  

Frazier, at first gained admission to study history and literature at law school, [1] but switched to medicine, after being influenced by the writings of Anton Chekhov and William Carlos Williams. [1] [2] [4] Interviewed for medicine on the 4 July, he won a place at Baylor College of Medicine, atypically on the ability to answer a question on history. [1] He subsequently completed his BA degree in history from the University of Texas-Austin in 1963 before commencing medical education. [5]

Medical education

Baylor College of Medicine (BCM) Baylor College of Medicine, Houston, Texas.jpg
Baylor College of Medicine (BCM)

As a medical student at BCM in 1964, he assisted in experimental total artificial hearts (TAH) research, which placed him under the mentorship of Michael E. DeBakey, Domingo Liotta and Denton A. Cooley, [1] [6] who five years later, controversially became the first to implant one. [7]

In 1966, at the age of 25, while still a medical student of DeBakey, who he described as a “tough taskmaster”, [8] an experience with a teenager who had just had an aortic valve repair, left a lasting impression on him. Frazier was required to manually massage the teenager's heart following a cardiac arrest. [9] He has since repeatedly recounted "that as long as I was massaging that kid's heart, he would wake up... I thought then, and I've often returned to this: If my hand can keep this kid alive, why couldn't we make a device to do the same?" [10] It was this incident and the experience with DeBakey's research that instilled his interest in cardiac surgery and MCS's. [6]

Of the twenty four students that Frazier started his residency with, only five were left. DeBakey, intolerable of error, fired most. [1]

Upon graduating with an MD in 1967, he also received the DeBakey Award for Outstanding Surgical Student [11] before then completing his residency at Baylor Affiliated Hospitals in 1968. [5]

Vietnam

Frazier served in the United States Army from 1968 to 1970 and distinguished himself as a flight surgeon in the U.S. Army 48th Assault Helicopter Company in Vietnam. [5] Once, he was shot down and on return to the States, has described how demoralised he felt about what men were capable of during war. [1]

For his achievements, he received three medals, the Combat Flight Medal, Vietnamese Navy Medal, and the Vietnamese Distinguished Service Medal. [2]

Surgical career

After Vietnam, Frazier returned as a surgical resident to BCM. [5]

He remained at BCM until 1974 when he gravitated towards LVAD-research at the near-by THI and subsequently joined Baylor's new rival Cooley, at the THI for further surgical training, which he completed in 1976. [5] [7] [11]

Left ventricular assist devices (LVAD) and total artificial hearts (TAH)

Throughout the 1970s and 1980s, he continued experimental work toward the development of the implantable long-term pulsatile HeartMate I LVAD. [6] [12] In 1976, he worked with John C. Norman and the first intra-abdominal LVAD. [12] In 1985, during his tenure on the advisory board of the National Heart, Lung, and Blood Institute (NHLBI), Frazier recommended that research be initiated on a TAH that would be fully implantable and that would allow people to be discharged and to live a normal lifestyle. [13] In 1986, Frazier successfully used the HeartMate I LVAD in a person with severe irreversible heart failure who was waiting for a heart transplant. Driven by compressed air, the HeartMate LVAD had a textured blood-contacting inner surface, in contrast to a smooth surface. This encouraged a living lining of endothelial cells resembling the inner surfaces of arteries and veins and hence required less blood thinning drugs. [6] [11] [12]

Over the course of four decades, his work in the field of other LVAD prototypes, continued with experimental studies that resulted in the first intravascular, implantable, continuous-flow pump (Hemopump), which he first implanted into a human in April 1988. [13] [14]

When funding for TAH research was restored in January 1991, Frazier became involved in further animal experiments. [13] In 1994, he instigated research on the HeartWare LVAD and described the first long-term clinical use of a LVAD. This person was the first to make hospital discharge with a LVAD. [11] His most significant contribution was the development of the nonpulsatile implantable LVADs, the Jarvik, HeartMate II and HeartWare. [6] After more than ten years of research, in 2000, he performed the first implant of the Jarvik 2000 LVAD into a human, also a continuous flow pump. [1]

By the end of 2013, Frazier and his THI team had implanted their 1,000th LVAD, more than fifty years after Cooley founded the THI and just short of fifty years after DeBakey at BCM was awarded the original NHI grant for the development of an artificial heart. [11] [15] His innovations in the surgical treatment of severe heart failure, heart transplantation and MCS to be used either to substitute for or to assist the pumping action of the human heart led to the THI gaining a reputation as a global leader of transplantation and MCS programmes. Frazier performed more than 1,300 heart transplants and implanted 1,000 LVADs, exceeding the performance of any other contemporary surgeon in the world during his career. [6] [12]

Successful implantation of a continuous flow device

'Heartmate' left ventricular-assist device, United States Wellcome L0066304 'Heartmate' left ventricular-assist device, United States Wellcome L0066304.jpg
‘Heartmate’ left ventricular-assist device, United States Wellcome L0066304

In March 2011, Craig Lewis was suffering from amyloidosis and not eligible for heart transplant due to the severity and extent of the disease, affecting also his kidney and liver. Unsuitable for a heart transplant, temporary mechanical TAH or LVAD, his small diseased heart was replaced with a continuous flow device, a pair of HeartMate II pumps, an apparatus of two pumps embraced together, following six years of research on more than fifty calves at the Texas Institute. He awoke from a coma and spent the last five weeks of his life interacting with his family. During the following year, Frazier and his colleague William Cohn engaged with the public and professionals on their experiences. Their TEDMED talk introduced them to Daniel Timms, who was driven to find a technological resolution and whose father had died of heart failure. Timms had an idea and sought out Frazier and Cohn in the States. The surgeons became interested, particularly with the idea that Timms's device had the potential to be a small size. Trialed in numerous calves between 2013 and 2016, some were able to run a treadmill after implantation. [16] [17]

Appointments

Frazier has been Professor of surgery at the University of Texas Health Science Center in Houston, [18] Clinical professor of surgery at the University of Texas M.D. Anderson Cancer Center, co-director of Center for Preclinical Surgical & Interventional Research at the Texas Heart Institute, and Tenured professor at Baylor College of Medicine. [19] [20] [21]

He has served on the editorial boards of several medical journals, including Circulation , the Journal of the American Heart Association , and The Journal of Heart and Lung Transplantation . [5]

He was a chairman of the federal affairs committee for the American Society for Artificial Internal Organs and served on other prominent national committees, including the education committee of the American Society of Transplant Surgeons[ citation needed ] and the advisory board of the NHLBI. [13]

Frazier served as president of The Denton A. Cooley Surgical Society and the American Society for Artificial Internal Organs. [22] [23]

Awards and honors

Medical honors include the Living Legend Award from the World Society of Cardiothoracic Surgeons, BCM Distinguished Alumnus Award, University of Texas Distinguished Alumnus Award, the Gift to Mankind Award from the American Organ Transplant Association, the Distinguished Surgeon Award from the Houston Surgical Society, Honored Physician Award from the American Heart Association Guild, the Ray C. Fish Award for Scientific Achievement from the Texas Heart Institute [19] and the Denton A. Cooley Cardiovascular Surgical Society International Recognition Award. In 2014, Dr. Frazier was presented with the Lifetime Achievement and Distinguished Faculty Award from the Michael E. DeBakey department of surgery at BCM. Frazier's award presentation preceded keynote speaker, former Vice President Dick Cheney, whose life was extended by the technology Frazier helped to develop. [24]

Since 2014, the International Society of Heart and Lung Transplantation (ISHLT) has awarded the "O.H. Frazier Award" in MCS Translational Research sponsored by Medtronic. [25]

In 2018, the ISHLT awarded Frazier with their ISHLT Lifetime Achievement Award in acknowledgement of his work on severe heart failure, heart transplantation and mechanical circulatory support. [6]

In 2021, The American Association for Thoracic Surgery (AATS) distinctly honored Frazier with the Scientific Achievement Award, the highest recognition the Association can bestow. [26] Previous recipients include Dr. Michael DeBakey, Dr. Denton Cooley, and Sir Magdi Yacoub. [27]

Published in 2018, a book entitled Ticker, recounts the story of Frazier's task to construct a sustainable totally implantable artificial heart. [28] The author describes Frazier sharing traits with pioneers in other fields [29] and how for over half a century been driven by the desire to save lives. [28] In response, reviewers have either been intrigued to what drives Frazier [28] or have debated the ethics surrounding TAHs and LVADs. [29]

Personal and family

Frazier has previously led Sunday school and collects rare books. [2] He is married to Rachel, and they have two children, Todd, who graduated from the Juilliard School of Music and became a composer, and Allison, a writer. [1]

Selected publications

Related Research Articles

<span class="mw-page-title-main">William DeVries</span> American physician

William Castle DeVries is an American cardiothoracic surgeon, mainly known for the first transplant of a TAH using the Jarvik-7 model.

<span class="mw-page-title-main">Artificial heart</span> Mechanical device which replaces the heart

An artificial heart is a device that replaces the heart. Artificial hearts are typically used to bridge the time to heart transplantation, or to permanently replace the heart in the case that a heart transplant is impossible. Although other similar inventions preceded it from the late 1940s, the first artificial heart to be successfully implanted in a human was the Jarvik-7 in 1982, designed by a team including Willem Johan Kolff, William DeVries and Robert Jarvik.

<span class="mw-page-title-main">Michael DeBakey</span> Lebanese-American surgeon and innovator (1908–2008)

Michael Ellis DeBakey was an American general and cardiovascular surgeon, scientist and medical educator who became Chairman of the Department of Surgery, President, and Chancellor of Baylor College of Medicine at the Texas Medical Center in Houston, Texas. His career spanned nearly eight decades.

<span class="mw-page-title-main">Baylor College of Medicine</span> Medical school in Houston, Texas

Baylor College of Medicine (BCM) is a medical school and research center in Houston, Texas, within the Texas Medical Center, the world's largest medical center. BCM is composed of four academic components: the School of Medicine, the Graduate School of Biomedical Sciences; the School of Health Professions, and the National School of Tropical Medicine.

<span class="mw-page-title-main">Denton Cooley</span> American heart and cardiothoracic surgeon (1920–2016)

Denton Arthur Cooley was an American cardiothoracic surgeon famous for performing the first implantation of a total artificial heart. Cooley was also the founder and surgeon in-chief of The Texas Heart Institute, chief of Cardiovascular Surgery at clinical partner Baylor St. Luke's Medical Center, consultant in Cardiovascular Surgery at Texas Children's Hospital and a clinical professor of Surgery at the University of Texas Health Science Center at Houston.

<span class="mw-page-title-main">Ventricular assist device</span> Medical device to assist or replace a heart

A ventricular assist device (VAD) is an electromechanical device for assisting cardiac circulation, which is used either to partially or to completely replace the function of a failing heart. The function of a VAD differs from that of an artificial cardiac pacemaker in that a VAD pumps blood, whereas a pacemaker delivers electrical impulses to the heart muscle. Some VADs are for short-term use, typically for patients recovering from myocardial infarction (heart attack) and for patients recovering from cardiac surgery; some are for long-term use (months to years to perpetuity), typically for patients with advanced heart failure.

Pierre Rene Grondin, was a Canadian cardiac surgeon who was one of the first doctors to perform a successful heart transplant. He was legendary in his surgical abilities and style and brought many innovations to the Montreal Heart Institute after his post-graduate training with pioneers Michael DeBakey and Denton Cooley in Houston, Texas. He was one of a select few heart surgeons worldwide who participated in the development of open heart surgery using the heart-lung machine in the early 1960s. He performed the first Canadian heart transplantation at the Montreal Heart Institute in May, 1968 shortly after the first successful heart transplant in the world in December, 1967 in Cape Town, South Africa by Dr. Christiaan Barnard.

<span class="mw-page-title-main">Domingo Liotta</span> Argentinian surgeon (1924–2022)

Domingo Santo Liotta was an Argentine surgeon and pioneer of heart surgery who created multiple cardiac prostheses, including the first total [[artificial heart{

Norman Edward Shumway was a pioneer of heart surgery at Stanford University. He was the 67th president of the American Association for Thoracic Surgery and the first to perform an adult human to human heart transplantation in the United States.

Charles D Fraser, Jr. is the medical director and surgeon of the Texas Center for Pediatric and Congenital Heart Disease at Dell Children's Medical Center. Formerly, Fraser was chief of congenital heart surgery and cardiac surgeon-in-charge at Texas Children's Hospital, the nation's largest pediatric hospital, served as chief of the Congenital Heart Surgery Division at Baylor College of Medicine, and director of the Adult Congenital Heart Surgery Program at the Texas Heart Institute.

James K. Kirklin is an American cardiac surgeon who has made significant scientific and surgical contributions in the fields of heart transplantation and mechanical circulatory support devices to assist the pumping action of the heart. He was formerly Professor of Surgery (1987-2022), Director of the Division of Cardiothoracic Surgery (2006-2016), Director of the James and John Kirklin Institute for Research in Surgical Outcomes (KIRSO) (2016–2022), and Co-Director of Comprehensive Cardiovascular Center (2011-2017) at the University of Alabama at Birmingham (UAB). While at UAB, he held the UAB Cardiovascular Research Chair (1998-2006), the John Kirklin Chair of Cardiovascular Surgery (2006-2017), and the James Kirklin Chair of Cardiothoracic Surgery (2017-2022).

Sharon Ann Hunt is a cardiology professor and Director of the Post Heart Transplant Programme in Palo Alto, California and is affiliated with Stanford University Medical Center, professionally known for her work in the care of patients after heart transplantation.

Michael J. Reardon is an American cardiac surgeon and medical researcher. He is known for his work in heart autotransplantation for malignant heart tumors, an operation in which the surgeon removes the patient's heart, cuts out the malignant tumor, and reimplants the heart back in the patient's chest. He performed the first successful heart autotransplantation for a cancerous heart tumor in 1998.

<span class="mw-page-title-main">CHI St. Luke's Health</span>

CHI St. Luke's Health is a health system located in the Greater Houston area. It is a part of one of the largest health systems and the second largest faith-based health system in the United States, Catholic Health Initiatives. CHI St. Luke's Health's facilities have been recognized as some of the best in the nation.

<span class="mw-page-title-main">Christian Cabrol</span> French cardiac surgeon

Christian Emile Cabrol was a French cardiac surgeon best known for performing Europe's first heart transplant at Pitié-Salpêtrière Hospital in 1968.

Philip Caves (1940–1978) was an Irish cardiothoracic surgeon. In 1972, while at Stanford University, he pioneered the use of the bioptome and transvenous endomyocardial biopsy in the early diagnosis of heart transplant rejection. It was considered the most significant advance in antirejection therapy of the time. Awarded the British American Research Fellowship in 1971, Caves worked with pioneering cardiothoracic surgeon Norman Shumway at Stanford and became staff surgeon leading the transplant programme by 1973. A year later he went to Edinburgh as a senior lecturer in cardiac surgery, where he became particularly interested in pediatric cardiac surgery.

<span class="mw-page-title-main">International Society for Heart and Lung Transplantation</span>

The International Society for Heart and Lung Transplantation (ISHLT), established in 1981, is a professional organization committed to research and education in heart and lung disease and transplantation. It holds annual scientific meetings and publishes The Journal of Heart and Lung Transplantation. It also holds the worlds largest registry of heart and lung transplant data.

Jack Greene Copeland is an American cardiothoracic surgeon, who has established procedures in heart transplantation including repeat heart transplantation, the implantation of total artificial hearts (TAH) to bridge the time to heart transplant, innovations in left ventricular assist devices (LVAD) and the technique of "piggybacking" a second heart in a person, while leaving them the original.

Eric A. Rose is an American cardiothoracic surgeon, scientist, entrepreneur and professor and Chairman of the Department of Population Health Science & Policy, and Associate Director for Clinical Outcomes at Mount Sinai Heart. He is best known for performing the first successful paediatric heart transplant, in 1984 while at NewYork–Presbyterian Hospital (NYP).

<span class="mw-page-title-main">Keith Reemtsma</span> American surgeon

Keith Reemtsma was an American transplant surgeon, best known for the cross-species kidney transplantation operation from chimpanzee to human in 1964. With only the early immunosuppressants and no long-term dialysis, the female recipient survived nine months, long enough to return to work.

References

  1. 1 2 3 4 5 6 7 8 9 10 11 Berger, Eric (29 April 2007). "Houstonsurgeon a leader in heart transplant field". Houston Chronicle. Retrieved 8 November 2018.
  2. 1 2 3 4 5 6 7 Communications, Emmis (October 1993). TheAlcalde. Emmis Communications. p. 43.
  3. ↑ Patsilelis, Chris. "Mimi Swartz's 'Ticker': The astonishing half-century quest for an artificial human heart". The Inquirer. Retrieved 7 November 2018.
  4. ↑ White, Andrea (14 March 2015). "Bigidea: Replacing the human heart". HoustonChronicle.com. Retrieved 8 November 2018.
  5. 1 2 3 4 5 6 "O. H. Frazier, M.D., Distinguished Cardiopulmonary Transplantat Surgeon, Scientist, and Academician". 7 December 2013. Archived from the original on 2013-12-07. Retrieved 7 November 2018.
  6. 1 2 3 4 5 6 7 "Dr. Frazier Awarded 2018 ISHLT Lifetime Achievement Award". Baylor College of Medicine. Retrieved 7 November 2018.
  7. 1 2 Altman, Lawrence K. "Dr. Michael E. DeBakey and Dr. Denton A. Cooley - Heart Surgeons- The Feud". The New York Times. Retrieved 9 November 2018.
  8. ↑ "Transcript: DeBakey Video Profile". www.nlm.nih.gov. Retrieved 7 November 2018.
  9. ↑ Hixenbaugh, Mike (2017-04-18). "Five decades later, famed surgeon Bud Frazier continues quest for an artificial heart". Houston Chronicle. Retrieved 2022-08-08.
  10. ↑ De Jesus, Marie D. (18 April 2017). "Five decades later, famed surgeon Bud Frazier continues quest for an artificial heart". HoustonChronicle.com. Retrieved 7 November 2018.
  11. 1 2 3 4 5 Rosengart, Todd K. (2014). "The 1,000th VAD, the great rivalry, and the grand experiment of the Texas Medical Center". The Journal of Thoracic and Cardiovascular Surgery. 147 (6): 1745–1747. doi:10.1016/j.jtcvs.2014.02.040. ISSN   0022-5223. PMID   24837721.
  12. 1 2 3 4 McKellar, Shelley (2018). Artificial Hearts: The Allure and Ambivalence of a Controversial Medical Technology. Johns Hopkins University Press. pp. 194–195. ISBN   978-1-4214-2355-5.
  13. 1 2 3 4 Fox, Renee C. (2017). Spare Parts: Organ Replacement in American Society. Routledge. ISBN   9781351488525.
  14. ↑ Morgan, Jeffrey A.; Civitello, Andrew B.; Frazier, O. H. (2017-12-06). Mechanical Circulatory Support for Advanced Heart Failure: A Texas Heart Institute/Baylor College of Medicine Approach. Springer. ISBN   9783319653648.
  15. ↑ McKellar, Shelley (2018), p.318
  16. ↑ Walker, Andy; Walker, Kay Svela; Carruthers, Sean (2016). Super You: How Technology is Revolutionizing What It Means to Be Human. Que Publishing. p. 198. ISBN   9780133790702.
  17. ↑ Baum, Dan (29 February 2012). "No Pulse: How Doctors Reinvented The Human Heart". Popular Science. Retrieved 7 November 2018.
  18. ↑ "O.H. Frazier, MD | Texas Heart Institute". www.texasheart.org. Retrieved 6 November 2018.
  19. 1 2 "O Howard Frazier, M.D." Baylor College of Medicine. Retrieved 6 November 2018.
  20. ↑ de 2022, 10 de Mayo. "Quiénes son los 12 Médicos e investigadores en Houston de mayor impacto mundial según la lista "Key Opinion Leaders"". infobae (in European Spanish). Retrieved 2022-08-09.
  21. ↑ "O.H. Frazier, MD". Texas Heart Institute. Retrieved 2022-08-09.
  22. ↑ "Legendary Heart Surgeon Honored and Sunny Med Center Cocktail Party". Houston CityBook. 2021-08-06. Retrieved 2022-08-09.
  23. ↑ Pearce, Jeremy (2009-02-20). "Peer Portner, Heart Pioneer, Dies at 69". The New York Times. ISSN   0362-4331 . Retrieved 2022-08-09.
  24. ↑ "Surgery News" (PDF). Baylor College of Medicine-. 2014. p. 4.
  25. ↑ Transplantation, International Society for Heart & Lung (24 March 2017). ISHLT 2017 Final Program. CTI Meeting Technology.
  26. ↑ "Dr. Frazier Receives 2021 AATS Scientific Achievement Award". Baylor College of Medicine. Retrieved 2022-08-09.
  27. ↑ "Scientific Achievement Award". AATS. Retrieved 2022-08-09.
  28. 1 2 3 Sofia, Sokolove (1 November 2018). "A New Book Tells the Story of Longhorn O.H. "Bud" Frazier and His Quest to Build an Artificial Heart". The Alcalde. Retrieved 8 November 2018.
  29. 1 2 Zhang, Sarah (17 September 2018). "The Quest to Create and Perfect an Artificial Heart". The New York Times. Retrieved 7 November 2018.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.